Xuebijing attenuates hypotension through the upregulation of angiotensin II type 1 receptor-associated protein 1 in rats suffering from heat stroke

International Journal of Molecular Medicine

Volumn 34, Issue 6, 2014, Pages 1699-1705

  Pan, Zhiguo ^a   Shao, Yu ^a   Dong, Wenpeng ^a   Liu, Chenxi ^a   Chen, Yi ^a   Jin, Hui ^a   Tang, Liqun ^a   Qiu, Junming ^a   Su, Lei ^a  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

Angiotensin II type 1 receptor; Angiotensin II type 1 receptor associated protein 1; Heat stroke; Inflammation; Nuclear factor B; Xuebijing

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR TYPE 1; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR ASSOCIATED PROTEIN 1; CHINESE DRUG; HYPERTENSIVE AGENT; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG; XUEBIJING; ANGIOTENSIN 1 RECEPTOR; ANGPTL2 PROTEIN, RAT; AUTACOID; CYTOKINE; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; DRUG MECHANISM; HEART RATE; HEAT STROKE; HYPERTENSION; HYPOTENSION; MALE; NONHUMAN; RAT; TEMPERATURE; UPREGULATION; ANIMAL; BLOOD; CELL LINE; CELL MEMBRANE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; MACROPHAGE; METABOLISM; PHYTOTHERAPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WISTAR RAT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANGIOTENSIN II; ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL MEMBRANE; CYTOKINES; DRUGS, CHINESE HERBAL; GENE EXPRESSION; HEAT STROKE; HYPOTENSION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; NF-KAPPA B; PHYTOTHERAPY; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84908059540     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1950     Document Type: Article

References (47)

1. Knochel JP: Disorders due to heat and cold. In: Textbook of Medicine. Wyngaarden JB and Smith LH (eds). Saunders, Philadelphia, pp 2304-2306, 1985.
2. Semenza JC, Rubin CH, Falter K.H., et al: Heat-related deaths during the July 1995 heat wave in Chicago. N Engl J Med 335: 84-90, 1996.
3. Robine JM, Cheung SL, Le Roy S, et al: Death toll exceeded 70,000 in Europe during the summer of 2003. C R Biol 331: 171-178, 2008.
4. Leon LR, Blaha MD and DuBose DA: Time course of cytokine, corticosterone, and tissue injury responses in mice during heat strain recovery. J Appl Physiol (1985) 100: 1400-1409, 2006.
5. Lu KC, Wang JY, Lin S.H., Chu P and Lin YF: Role of circulating cytokines and chemokines in exertional heatstroke. Crit Care Med 32: 399-403, 2004.
6. Bouchama A, Ollivier V, Roberts G., et al: Experimental heatstroke in baboon: analysis of the systemic inflammatory response. Shock 24: 332-335, 2005.
7. Bouchama A, Hammami MM, Al Shail E and De Vol E: Differential effects of in vitro and in vivo hyperthermia on the production of interleukin-10. Intensive Care Med 26: 1646-1651, 2000.
8. Bouchama A, al-Sedairy S, Siddiqui S., Shail E and Rezeig M: Elevated pyrogenic cytokines in heatstroke. Chest 104: 1498-1502, 1993.
9. Hammami MM, Bouchama A, Al-Sedairy S, et al: Concentrations of soluble tumor necrosis factor and interleukin-6 receptors in heatstroke and heatstress. Crit Care Med 25: 1314-1319, 1997.
10. Hashim IA, Al-Zeer A, Al-Shohaib S, Al-Ahwal M and Shenkin A: Cytokine changes in patients with heatstroke during pilgrimage to Makkah. Mediators Inflamm 6: 135-139, 1997.
11. Bouchama A and Knochel JP: Heat stroke. N Engl J Med 346: 1978-1988, 2002.
12. Bouchama A, Roberts G, Al Mohanna F, et al: Inflammatory, hemostatic, and clinical changes in a baboon experimental model for heatstroke. J Appl Physiol (1985) 98: 697-705, 2005.
13. Lin MT, Kao TY, Jin YT and Chen CF: Interleukin-1 receptor antagonist attenuates the heat stroke-induced neuronal damage by reducing the cerebral ischemia in rats. Brain Res Bull 37: 595-598, 1995.
14. Lin MT, Liu HH and Yang YL: Involvement of interleukin-1 receptor mechanisms in development of arterial hypotension in rat heatstroke. Am J Physiol 273: H2072-H2077, 1997.
15. Cumming AD, Driedger AA, McDonald J.W., et al: Vasoactive hormones in the renal response to systemic sepsis. Am J Kidney Dis 11: 23-32, 1988.
16. Hilgenfeldt U, Kienapfel G, Kellermann W., Schott R and Schmidt M: Renin-angiotensin system in sepsis. Clin Exp Hypertens A 9: 1493-1504, 1987.
17. Benedict CR and Rose JA: Arterial norepinephrine changes in patients with septic shock. Circ Shock 38: 165-172, 1992.
18. Castrop H: Angiotensin receptor-associated proteins: local modulators of the renin-angiotensin system. Pflugers Arch 465: 111-119, 2013.
19. Kai H, Griendling KK, Lassègue B, et al: Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptor. Hypertension 24: 523-527, 1994.
20. Guo DF, Chenier I, Tardif V., Orlov SN and Inagami T: Type 1 angiotensin II receptor-associated protein ARAP1 binds and recycles the receptor to the plasma membrane. Biochem Biophys Res Commun 310: 1254-1265, 2003.
21. Doblinger E, Höcherl K, Mederle K., et al: Angiotensin AT1 receptor-associated protein Arap1 in the kidney vasculature is suppressed by angiotensin II. Am J Physiol Renal Physiol 302: F1313-F1324, 2012.
22. Mederle K, Schweda F, Kattler V., et al: The angiotensin II AT1 receptor-associated protein Arap1 is involved in sepsis-induced hypotension. Crit Care 17: R130, 2013.
23. Chen Y, Tong H, Zhang X., et al: Xuebijing injection alleviates liver injury by inhibiting secretory function of Kupffer cells in heat stroke rats. J Tradit Chin Med 33: 243-249, 2013.
24. Jiang M, Zhou M, Han Y., et al: Identification of NF-κB inhibitors in Xuebijing injection for sepsis treatment based on bioactivity-integrated UPLC-Q/TOF. J Ethnopharmacol 147: 426-433, 2013.
25. Chen SH, Chang FM, Niu K.C., Lin MY and Lin MT: Resuscitation from experimental heatstroke by estrogen therapy. Crit Care Med 34: 1113-1118, 2006.
26. Chen CM, Hou CC, Cheng K.C., et al: Activated protein C therapy in a rat heat stroke model. Crit Care Med 34: 1960-1966, 2006.
27. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta (CT)) method. Methods 25: 402-408, 2001.
28. Ohtani R, Ohashi Y, Muranaga K., Itoh N and Okamoto H: Changes in activity of the renin-angiotensin system of the rat by induction of acute inflammation. Life Sci 44: 237-241, 1989.
29. Rodriguez-Fernandez M., Grosman B, Yuraszeck T.M., et al: Modeling the intra- and extracellular cytokine signaling pathway under heat stroke in the liver. PLoS One 8: e73393, 2013.
30. Gilmore TD: Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25: 6680-6684, 2006.
31. Watanabe T, Miyoshi M and Imoto T: Angiotensin II: its effects on fever and hypothermia in systemic inflammation. Front Biosci 9: 438-447, 2004.
32. Paradis P, Dali-Youcef N, Paradis F W, Thibault G and Nemer M: Overexpression of angiotensin II type I receptor in cardiomy-ocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci USA 97: 931-936, 2000.
33. Hall JE: Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation. Am J Physiol 250: R960-R972, 1986.
34. Hall JE and Granger JP: Adenosine alters glomerular filtration control by angiotensin II. Am J Physiol 250: F917-F923, 1986.
35. Hunyady L, Catt KJ, Clark AJ and Gáborik Z: Mechanisms and functions of AT(1) angiotensin receptor internalization. Regul Pept 91: 29-44, 2000.
36. Gaborik Z, Szaszák M, Szidonya L., et al: Beta-arrestin- and dynamin-dependent endocytosis of the AT1 angiotensin receptor. Mol Pharmacol 59: 239-247, 2001.
37. Perry SJ and Lefkowitz RJ: Arresting developments in hepta-helical receptor signaling and regulation. Trends Cell Biol 12: 130-138, 2002.
38. Tohgo A, Pierce KL, Choy E.W., Lefkowitz RJ and Luttrell LM: beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J Biol Chem 277: 9429-9436, 2002.
39. Smith RD, Baukal AJ, Zolyomi A, et al: Agonist-induced phosphor ylation of the endogenous AT1 angiotensin receptor in bovine adrenal glomerulosa cells. Mol Endocrinol 12: 634-644, 1998.
40. Smith RD, Hunyady L, Olivares-Reyes JA, et al: Agonist-induced phosphorylation of the angiotensin AT1a receptor is localized to a serine/threonine-rich region of its cytoplasmic tail. Mol Pharmacol 54: 935-941, 1998.
41. Conchon S, Peltier N, Corvol P and Clauser E: A noninter-nalized nondesensitized truncated AT1A receptor transduces an amplified ANG II signal. Am J Physiol 274: E336-E345, 1998.
42. Hunyady L, Bor M, Balla T and Catt KJ: Identification of a cytoplasmic Ser-Thr-Leu motif that determines agonist-induced internalization of the AT1 angiotensin receptor. J Biol Chem 269: 31378-31382, 1994.
43. Tang H, Guo DF, Porter J P, Wanaka Y and Inagami T: Role of cytoplasmic tail of the type 1A angiotensin II receptor in agonist- and phorbol ester-induced desensitization. Circ Res 82: 523-531, 1998.
44. Hagiwara S, Iwasaka H, Matumoto S., Hidaka S and Noguchi T: Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models. Crit Care Med 37: 626-633, 2009.
45. Ghosh S and Hayden MS: New regulators of NF-kappaB in inflammation. Nat Rev Immunol 8: 837-848, 2008.
46. Watters TM, Kenny EF and O'Neill LA: Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins. Immunol Cell Biol 85: 411-419, 2007.
47. Li T: Avoiding adverse drug reactions to Chinese medicine injections. J Evid Based Med 3: 44-49, 2010.